Letter

Nature 443, 713-716 (12 October 2006) | doi:10.1038/nature05164; Received 7 June 2006; Accepted 17 August 2006; Published online 10 September 2006

The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates

Ivan Ahel1, Ulrich Rass1, Sherif F. El-Khamisy2,3, Sachin Katyal4, Paula M. Clements2, Peter J. McKinnon4, Keith W. Caldecott2 and Stephen C. West1

Ataxia oculomotor apraxia-1 (AOA1) is a neurological disorder caused by mutations in the gene (APTX) encoding aprataxin1, 2. Aprataxin is a member of the histidine triad (HIT) family of nucleotide hydrolases and transferases3, and inactivating mutations are largely confined to this HIT domain. Aprataxin associates with the DNA repair proteins XRCC1 and XRCC4, which are partners of DNA ligase III and ligase IV, respectively4, 5, 6, 7, suggestive of a role in DNA repair. Consistent with this, APTX-defective cell lines are sensitive to agents that cause single-strand breaks and exhibit an increased incidence of induced chromosomal aberrations4, 5, 8. It is not, however, known whether aprataxin has a direct or indirect role in DNA repair, or what the physiological substrate of aprataxin might be. Here we show, using purified aprataxin protein and extracts derived from either APTX-defective chicken DT40 cells or Aptx-/- mouse primary neural cells, that aprataxin resolves abortive DNA ligation intermediates. Specifically, aprataxin catalyses the nucleophilic release of adenylate groups covalently linked to 5'-phosphate termini at single-strand nicks and gaps, resulting in the production of 5'-phosphate termini that can be efficiently rejoined. These data indicate that neurological disorders associated with APTX mutations may be caused by the gradual accumulation of unrepaired DNA strand breaks resulting from abortive DNA ligation events.

  1. Cancer Research UK, London Research Institute, Clare Hall Laboratories, South Mimms, Herts EN6 3LD, UK
  2. Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK
  3. Biochemistry Department, Faculty of Pharmacy, Ain Shams University, PO Box 11566, Cairo, Egypt
  4. Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, 332N Lauderdale, Memphis, Tennessee 38105, USA

Correspondence to: Stephen C. West1 Correspondence and requests for materials should be addressed to S.C.W. (Email: stephen.west@cancer.org.uk).

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT